Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial.

MLA

Rath, Timo, et al. “Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial.” Gastroenterology, vol. 164, no. 2, Feb. 2023, pp. 241–55. EBSCOhost, https://doi.org/10.1053/j.gastro.2022.10.014.

APA

Rath, T., Atreya, R., Bodenschatz, J., Uter, W., Geppert, C. E., Vitali, F., Fischer, S., Waldner, M. J., Colombel, J.-F., Hartmann, A., & Neurath, M. F. (2023). Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial. Gastroenterology, 164(2), 241–255. https://doi.org/10.1053/j.gastro.2022.10.014

Chicago

Rath, Timo, Raja Atreya, Julia Bodenschatz, Wolfgang Uter, Carol E Geppert, Francesco Vitali, Sarah Fischer, et al. 2023. “Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial.” Gastroenterology 164 (2): 241–55. doi:10.1053/j.gastro.2022.10.014.